Complete British News World

UK Introduced the Oxford AstraZeneca Coronal Vaccine |  Foreigner

UK Introduced the Oxford AstraZeneca Coronal Vaccine | Foreigner

Today the UK was the first country to start mass vaccination with the pharmaceutical company AstraZeneca. The vaccine is a collaboration between the company and the University of Oxford.

The first to get the vaccine was 82-year-old dialysis patient Brian Pinker. The vaccine was received at Oxford University Hospital, a few hundred meters from the laboratory where it was developed.

“I am very happy to receive the vaccine today, and I am proud that it was developed in Oxford,” Pinker said.

The UK approved the vaccine five days ago.

Cheaper and easier to store

AstraZeneca vaccine is inexpensive and easy to dispense – it can be stored at fridge temperatures between two and eight degrees. In comparison, the Pfizer-Biontech vaccine should be stored at -70 degrees.

A shot of a vaccine costs just over 2 pounds, which equates to 2.20 euros.

This is a success for British science. British Health Secretary Matt Hancock told Sky News from the start, we realized that a vaccine was the only way out.

The European Union is lagging behind

The UK began vaccinating the Pfizer-Biontech vaccine in December, after being approved as the first country in the West.

The UK has so far vaccinated more than 1 million people. This is more than what has been vaccinated in the European Union as a whole.

The European Union has approved 300 million doses of the Oxford-AstraZeneca vaccine, 200 million doses of the Pfizer-Biontech vaccine and 80 million doses of the Moderna vaccine.

The UK has withheld 100 million doses of the Oxford-AstraZeneca vaccine.

See also  Watv EV has signed an agreement with Comfort as the general contractor for the new charging infrastructure in Sweden

Vaccination in European Union member states has started slowly, and so far only the European Union has approved the Pfizer-Biontech vaccine.

The United States and Canada approved a vaccine from the US manufacturer Moderna before Christmas, and the European Union is expected to approve it this week.

Sources: Reuters, Agence France-Presse